Credit Suisse’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $336K | Buy |
4,682
+4
| +0.1% | +$287 | ﹤0.01% | 2784 |
|
|
2023
Q4 | $930K | Buy |
4,678
+448
| +11% | +$89.1K | ﹤0.01% | 2369 |
|
|
2023
Q3 | $562K | Sell |
4,230
-647
| -13% | -$86K | ﹤0.01% | 2607 |
|
|
2023
Q2 | $730K | Buy |
4,877
+96
| +2% | +$14.4K | ﹤0.01% | 2575 |
|
|
2023
Q1 | $702K | Buy |
4,781
+596
| +14% | +$87.5K | ﹤0.01% | 2522 |
|
|
2022
Q4 | $663K | Buy |
4,185
+1,773
| +74% | +$281K | ﹤0.01% | 2589 |
|
|
2022
Q3 | $463K | Buy |
2,412
+618
| +34% | +$119K | ﹤0.01% | 2814 |
|
|
2022
Q2 | $261K | Buy |
1,794
+202
| +13% | +$29.4K | ﹤0.01% | 3210 |
|
|
2022
Q1 | $280K | Buy |
1,592
+108
| +7% | +$19K | ﹤0.01% | 3237 |
|
|
2021
Q4 | $436K | Buy |
1,484
+49
| +3% | +$14.4K | ﹤0.01% | 3115 |
|
|
2021
Q3 | $357K | Buy |
1,435
+264
| +23% | +$65.7K | ﹤0.01% | 3189 |
|
|
2021
Q2 | $297K | Sell |
1,171
-136
| -10% | -$34.5K | ﹤0.01% | 3279 |
|
|
2021
Q1 | $231K | Buy |
1,307
+8
| +0.6% | +$1.41K | ﹤0.01% | 3234 |
|
|
2020
Q4 | $205K | Buy |
+1,299
| New | +$205K | ﹤0.01% | 3237 |
|